Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 May 22;16(5):e60872.
doi: 10.7759/cureus.60872. eCollection 2024 May.

Anti-factor H Autoantibody-Associated Hemolytic Uremic Syndrome: A Rare Entity in a Pediatric Patient

Affiliations
Case Reports

Anti-factor H Autoantibody-Associated Hemolytic Uremic Syndrome: A Rare Entity in a Pediatric Patient

Gaurav Singh et al. Cureus. .

Abstract

An 11-year-old patient presented with the primary complaint of hematuria and vomiting. On further investigation and a series of diagnostic tests, including a biopsy and thrombotic microangiopathy (TMA) profile, the patient was diagnosed with thrombotic microangiopathy. TMA is a pathological process involving endothelial cell injury, leading to thrombocytopenia and microangiopathic hemolytic anemia. This case highlights the importance of considering TMA in pediatric patients presenting with nonspecific symptoms, such as loss of appetite. Further research is needed to understand the pathophysiology and optimal management strategies for pediatric TMA. This case adds to the growing body of literature on pediatric TMA and underscores the need for a high index of suspicion in similar clinical scenarios.

Keywords: ahus; anti-factor h antibody; atypical hemolytic uremic syndrome; complement mediated hus; thrombotic microangiopathies; thrombotic thrombocytopenic purpura.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Light microscopy of renal biopsy specimen at 20×10 magnification showing subendothelial edema, ectatic capillary loops, focal mesangiolysis, and RBC fragmentation with capillary tuft retraction.
Figure 2
Figure 2. Electron microscopy of renal biopsy specimen showing foot process flattening with vacuolization of the lamina densa.

References

    1. Anti-factor H antibody and its role in atypical hemolytic uremic syndrome. Raina R, Mangat G, Hong G, et al. Front Immunol. 2022;13 - PMC - PubMed
    1. Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome. Dragon-Durey MA, Sethi SK, Bagga A, et al. J Am Soc Nephrol. 2010;21:2180–2187. - PMC - PubMed
    1. Anti-compliment factor H antibody associated hemolytic uremic syndrome in children with abbreviated plasma exchanges: a 12-month follow-up study. Tiewsoh K, Govindarajan S, Dawman L, Rawat A, Ramachandran R, Hans R. https://pubmed.ncbi.nlm.nih.gov/34930853/ Iran J Kidney Dis. 2021;15:419–425. - PubMed
    1. Complement and the atypical hemolytic uremic syndrome in children. Loirat C, Noris M, Fremeaux-Bacchi V. https://doi.org/10.1007/s00467-008-0872-4. Pediatr Nephrol. 2008;23:1957–1972. - PMC - PubMed

Publication types

LinkOut - more resources